Therefore, we further compared the levels of KMO mRNA expression in breast cancers (n = 1085) with those in normal breast tissues (n = 291) using the GEPIA database (Figure 1c,d), and the results also showed that KMO was overexpressed in breast cancers. This evidence concerns the gene KMO and breast carcinoma.